These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 10450429

  • 1. Reduction in the mean number of Plasmodium falciparum genotypes in Gambian children immunized with the malaria vaccine SPf66.
    Haywood M, Conway DJ, Weiss H, Metzger W, D'Alessandro U, Snounou G, Targett G, Greenwood B.
    Trans R Soc Trop Med Hyg; 1999 Feb; 93 Suppl 1():65-8. PubMed ID: 10450429
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Natural antibody responses to Plasmodium falciparum MSP3 and GLURP(R0) antigens are associated with low parasite densities in malaria patients living in the Central Region of Ghana.
    Amoah LE, Nuvor SV, Obboh EK, Acquah FK, Asare K, Singh SK, Boampong JN, Theisen M, Williamson KC.
    Parasit Vectors; 2017 Aug 23; 10(1):395. PubMed ID: 28835262
    [Abstract] [Full Text] [Related]

  • 4. Analysis of multiple Plasmodium falciparum infections in Tanzanian children during the phase III trial of the malaria vaccine SPf66.
    Beck HP, Felger I, Huber W, Steiger S, Smith T, Weiss N, Alonso P, Tanner M.
    J Infect Dis; 1997 Apr 23; 175(4):921-6. PubMed ID: 9086150
    [Abstract] [Full Text] [Related]

  • 5. Serological responses of Gambian children to immunization with the malaria vaccine SPf66.
    Metzger WG, Haywood M, D'Alessandro U, Drakeley CJ, Weiss H, Bojang K, Targett GA, Greenwood BM.
    Parasite Immunol; 1999 Jul 23; 21(7):335-40. PubMed ID: 10417667
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Follow-up of Gambian children recruited to a pilot safety and immunogenicity study of the malaria vaccine SPf66.
    Bojang KA, Obaro SK, Leach A, D'Alessandro U, Bennett S, Metzger W, Ballou WR, Targett GA, Greenwood BM.
    Parasite Immunol; 1997 Dec 23; 19(12):579-81. PubMed ID: 9458470
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Humoral immune responses during a malaria vaccine trial in Tanzanian infants.
    Galindo CM, Acosta CJ, Schellenberg D, Aponte JJ, Roca A, Oettli A, Urassa H, Armstrong Schellenberg J, Kahigwa E, Ascaso C, Mshinda H, Lwilla F, Vidal J, Menendez C, Tanner M, Alonso PL.
    Parasite Immunol; 2000 Sep 23; 22(9):437-43. PubMed ID: 10972850
    [Abstract] [Full Text] [Related]

  • 10. Plasmodium falciparum msp1 and msp2 genetic diversity and allele frequencies in parasites isolated from symptomatic malaria patients in Bobo-Dioulasso, Burkina Faso.
    Somé AF, Bazié T, Zongo I, Yerbanga RS, Nikiéma F, Neya C, Taho LK, Ouédraogo JB.
    Parasit Vectors; 2018 May 30; 11(1):323. PubMed ID: 29843783
    [Abstract] [Full Text] [Related]

  • 11. Vaccines for preventing malaria.
    Graves P, Gelband H.
    Cochrane Database Syst Rev; 2003 May 30; (1):CD000129. PubMed ID: 12535387
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A pilot safety and immunogenicity study of the malaria vaccine SPf66 in Gambian infants.
    Leach A, Drakeley CJ, D'Alessandro U, Fegan GW, Bennett S, Ballou WR, Targett GA, Greenwood BM.
    Parasite Immunol; 1995 Aug 30; 17(8):441-4. PubMed ID: 7501425
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Immunogenicity and in vivo efficacy of recombinant Plasmodium falciparum merozoite surface protein-1 in Aotus monkeys.
    Kumar S, Yadava A, Keister DB, Tian JH, Ohl M, Perdue-Greenfield KA, Miller LH, Kaslow DC.
    Mol Med; 1995 Mar 30; 1(3):325-32. PubMed ID: 8529111
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Randomised trial of efficacy of SPf66 vaccine against Plasmodium falciparum malaria in children in southern Tanzania.
    Alonso PL, Smith T, Schellenberg JR, Masanja H, Mwankusye S, Urassa H, Bastos de Azevedo I, Chongela J, Kobero S, Menendez C.
    Lancet; 1994 Oct 29; 344(8931):1175-81. PubMed ID: 7934537
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of parasite subpopulations and genetic diversity of the msp1, msp2 and glurp genes during and following artesunate monotherapy treatment of Plasmodium falciparum malaria in Western Cambodia.
    Gosi P, Lanteri CA, Tyner SD, Se Y, Lon C, Spring M, Char M, Sea D, Sriwichai S, Surasri S, Wongarunkochakorn S, Pidtana K, Walsh DS, Fukuda MM, Manning J, Saunders DL, Bethell D.
    Malar J; 2013 Nov 09; 12():403. PubMed ID: 24206588
    [Abstract] [Full Text] [Related]

  • 20. Immunogenicity of a chimeric Plasmodium falciparum merozoite surface protein vaccine in Aotus monkeys.
    Burns JM, Miura K, Sullivan J, Long CA, Barnwell JW.
    Malar J; 2016 Mar 15; 15():159. PubMed ID: 26975721
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.